Note: Ingredients listed on restricted chemical lists
EC/CAS
216-823-5/1675-54-3
Name of the chemical
2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
Concentration
≥5
General Information
Version
3.1
Revision date
2024-12-30
Product name
Mixture
1.2.1 Relevant identified uses
Epoxy repair putty stick
Icons in SDS
Company Information
company name
The Industrial Maintenance Group
e-mail address of the competent person responsible for the Safety Data Sheet
sales@img-limited.co.uk
GHS Information
Signal word
GHS07
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
H317 environment – Chronic Hazard, H412 Hazardous to the aquatic environment – Chronic Category Hazard, 3 H412 Category 3 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Harmful to aquatic life with long lasting effects. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : Hazard pictograms (CLP) : GHS07 Signal word (CLP) GHS07 : Warning Signal word (CLP) Contains : Warning : Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hydro-.omega.-hydroxy-, ether with 2,2- Contains
Hazard categories
H412 Category 3 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Harmful to aquatic life with long lasting effects
Hazard pictograms
GHS07
Signal word
GHS07 Warning
Contains
Warning Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hydro-.omega.-hydroxy-, ether with 2,2- Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hydro-.omega.-hydroxy-, bis(hydroxymethyl)-1,3-propanediol ether with 2,2- (4:1), 2-hydroxy-3-mercaptopropyl ether; bis-[4-(2,3- bis(hydroxymethyl)-1,3-propanediol (4:1), epoxipropoxi)phenyl]propane; 2-hydroxy-3-mercaptopropyl ether; Phenol, bis-[4-(2,3- Polymer with Formaldehyde, Glycidyl Ether
Hazard statements
epoxipropoxi)phenyl]propane; (CLP) Phenol, Polymer H315 - with Causes Formaldehyde, skin irritation. Glycidyl Ether H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H319 - Causes serious eye irritation. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
H412 - Harmful (CLP) to aquatic life with long lasting P261 effects. - Avoid breathing dust/fume/gas/mist/vapours/spray. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P264 - Wash hands, forearms and face thoroughly P280 - Wear after eye handling. protection, protective clothing, protective gloves. P280 - Wear eye protection, protective clothing, P321 - protective Specific treatment gloves. (see supplemental first aid instruction on this label). P321 - Specific treatment (see supplemental first aid instruction on this label). 12/30/2024 (Revision date) GB - en 1/10 P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse.
Supplemental label elements
EUH205 - Contains epoxy constituents. May produce an allergic reaction. EUH212 - Warning! Hazardous respirable dust may be formed when used. Do not breathe dust.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in bis-[4-(2,3-epoxipropoxi)phenyl]propane (1675-54-3) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605